We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cigarette Smoke Linked to Lung Cancer Mutation

By Biotechdaily staff writers
Posted on 28 Oct 2002
Researchers have found that benzo(a)pyrene diol expoxide (BPDE), a known carcinogen in cigarette smoke, causes mutations in the RAS gene, a finding that demonstrates a direct molecular link between smoking and lung cancer. More...
The finding was reported in the October 16, 2002, issue of the Journal of the National Cancer Institute.

RAS is a family of genes that have many biological functions but mainly control cell growth and development. Mutations in a RAS gene can lead to uncontrolled cell growth, and more than 30% of lung cancers, 90% of pancreatic cancers, and 50% of colon cancers are associated with mutations at a specific site in the K-RAS gene.

Using a sensitive gene mapping technique, investigators from New York University School of Medicine (NYU, USA) showed that BPDE preferentially bound to the K-RAS gene at codon 12, an area especially vulnerable to mutation and only marginally repairable. In addition, they found that BPDE did not bind significantly to other members of the RAS gene family.

Dr. Eric Moon-shong Tang, professor of environmental medicine at NYU School of Medicine, explained that the findings provide further proof that smoking does cause lung cancer because the carcinogen bound most strongly to the precise site in the K-RAS gene that is frequently mutated in lung cancer.



Related Links:
New York University Med. Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
POC Immunoassay Analyzer
Procise DX
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.